Thalwil, Switzerland

Nicolas Meier

This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Anjarium Biosciences Ag. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Nicolas Meier

Introduction

Nicolas Meier is a prominent inventor based in Thalwil, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the area of DNA molecule compositions. His work has implications for various applications in genetic engineering and molecular biology.

Latest Patents

Nicolas Meier holds a patent for "Compositions of DNA molecules, methods of making therefor, and methods of use thereof." This patent describes double strand DNA molecules that comprise inverted repeats, expression cassettes, and one or more restriction sites for nicking endonucleases. The methods of use and production of these DNA molecules are also detailed in the patent. He has 1 patent to his name.

Career Highlights

Nicolas Meier is currently employed at Anjarium Biosciences AG, where he continues to innovate and develop new technologies in the field of biotechnology. His expertise and research have positioned him as a valuable asset in his company.

Collaborations

Throughout his career, Nicolas has collaborated with notable colleagues, including Joel De Beer and Monique Maurer. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Nicolas Meier's contributions to the field of biotechnology through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to influence advancements in genetic engineering and molecular biology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…